2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult

Cited by (1,000)

Items 501–600 of 1,000

1. Relationship between lipoprotein (a) and subclinical carotid atherosclerosis in asymptomatic individuals
   Victor França, Érica Ivana Lázaro Gomes, Edite Vieira Silva de Campos, Vanessa Helena de Souza Zago, Valeria Sutti Nunes, Eliana Cotta de Faria · 2022 · Clinics
2. Changes in Lipoprotein(a) Levels in People after ST Elevation Myocardial Infarction—The STEMI-Lipids Study
   Caren Sourij, Faisal Aziz, Sarah Krappinger, Andreas Praschk, Thomas Metzner, Harald Kojzar, Andreas Zirlik, Tatjana Stojaković, Dieter Pätzold, Dirk von Lewinski et al. · 2023 · International Journal of Molecular Sciences
3. An Update on Dyslipidemia Management and Medications: A Review
   Ziad A Taher, Abdulrahman A Taher, Suhaib Radi · 2024 · Cureus
4. Lipoprotein (a) testing patterns among subjects with a measured lipid panel: The Mayo Clinic experience
   Matteo Manzato, Jeffery W. Meeusen, Leslie J. Donato, Allan S. Jaffe, Vlad C. Vasile · 2024 · American Journal of Preventive Cardiology
5. Cardiovascular disease risk prediction by Framingham risk score in women with polycystic ovary syndrome
   Mina Amiri, Maryam Mousavi, Mahsa Noroozzadeh, Fereidoun Azizi, Fahimeh Ramezani Tehrani · 2025 · Reproductive Biology and Endocrinology
6. Remnant Cholesterol: Should it be a Target for Prevention of ASCVD?
   Takahito Doi, Anne Langsted, Børge Grønne Nordestgaard · 2025 · Current Atherosclerosis Reports
7. Inconsistent Guideline Recommendations for Cardiovascular Prevention and the Debate About Zeroing in on and Zeroing LDL-C Levels With PCSK9 Inhibitors
   John P. A. Ioannidis · 2017 · JAMA
8. 2016 Guidelines for the management of dyslipidemia and the prevention of cardiovascular disease in adults by pharmacists
   Ricky D. Turgeon, Todd J. Anderson, Jean Grégoire, Glen J. Pearson · 2017 · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
9. Relationship between continuity of care and clinical outcomes in patients with dyslipidemia in Korea: a real world claims database study
   Juhee Lee, Eun-Young Choi, Eunjung Choo, Linda Siachalinga, Eun Jin Jang, Iyn‐Hyang Lee · 2022 · Scientific Reports
10. Dyslipidaemia in adults with type 1 diabetes—when to treat?
    Nick S.R. Lan, P. Gerry Fegan, Bu Beng Yeap, Damon A. Bell, Gerald Francis Watts · 2018 · Diabetes/Metabolism Research and Reviews
11. Identifying and managing younger women at high risk of cardiovascular disease
    Kajenny Srivaratharajah, Beth L. Abramson · 2019 · Canadian Medical Association Journal
12. Human High-Density Lipoprotein Microtranscriptome is Unique and Suggests an Extended Role in Lipid Metabolism
    Véronique Desgagné, Renée Guérin, Simon‐Pierre Guay, Marjorie Boyer, Elizabeth D. Hutchins, Samuel Picard, Alexandre Maréchal, François Corbin, Kendall R. Van Keuren‐Jensen, Benoît J. Arsenault et al. · 2019 · Epigenomics
13. Goals of non-high density lipoprotein cholesterol need to be adjusted in Chinese acute coronary syndrome patients: Findings from the CCC-ACS project
    Xin Su, Mengdie Luo, Xiaoyu Tang, Yonghong Luo, Xiaoyan Zheng, Daoquan Peng · 2019 · Clinica Chimica Acta
14. Calculated Non-HDL Cholesterol Includes Cholesterol in Larger Triglyceride-Rich Lipoproteins in Hypertriglyceridemia
    Cathy Sun, Christopher R. McCudden, Diane Brisson, Julie L. V. Shaw, Daniel Gaudet, Teik Chye Ooi · 2019 · Journal of the Endocrine Society
15. Is There a Role of Coronary CTA in Primary Prevention? Current State and Future Directions
    Martin Bødtker Mortensen, Michael Joseph Blaha · 2021 · Current Atherosclerosis Reports
16. Online clinical pathway for chronic kidney disease management in primary care: a retrospective cohort study
    Maoliosa Donald, Michelle D. Smekal, Meghan Jessica Elliott, Kerry McBrien, Robert G. Weaver, Braden Manns, Marcello A. Tonelli, Aminu Kasarawa Bello, Sharon Elizabeth Straus, Nairne Scott‐Douglas et al. · 2021 · BMC Nephrology
17. Benefit and Risk of Prolonged Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stents in Patients With Elevated Lipoprotein(a) Concentrations
    Kongyong Cui, Haoyu Wang, Dong Yin, Cheng‐Gang Zhu, Weihua Song, Hongjian Wang, Lei Jia, Dong Zhang, Chenxi Song, Lei Feng et al. · 2021 · Frontiers in Cardiovascular Medicine
18. Postpartum Cardiovascular Prevention: The Need for a National Health Systems-Based Strategy
    Natalie Dayan, Kara A. Nerenberg · 2019 · Canadian Journal of Cardiology
19. Do Triglyceride-Rich Lipoproteins Equal Low-Density Lipoproteins in Risk of ASCVD?
    Benjamin Nilsson Wadström, Anders Berg Wulff, Kasper Mønsted Pedersen, Børge Grønne Nordestgaard · 2023 · Current Atherosclerosis Reports
20. Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study
    Milan Gupta, Rajvi J. Wani, Khalid A. Al Faraidy, Jean Bergeron, Eduardo Contreras, Ángel Alberto García Peña, G.B. John Mancini, Francisco Padilla, Abel Alberto Pavía López, Kiran J. Philip et al. · 2023 · Cardiology and Therapy
21. In-silico and in-vivo comparative evaluation of the cardioprotective potential of Yellow turmeric and White turmeric in Mn-induced cardiac oxidative stress
    Toluwalope T. Fasooto, Oluwakemi R. Ogundana, Abiola F. Adebayo, David B. Olawade, Ezekiel Abiola Olugbogi, Oluwaseun Fapohunda, Afolabi Clement Akinmoladun · 2024 · Pharmacological Research - Modern Chinese Medicine
22. Review of Evolocumab for the Reduction of LDL Cholesterol and Secondary Prevention of Atherosclerotic Cardiovascular Disease
    Lawrence A. Leiter, Robert Alexander Hegele, Vivien Brown, Jean Bergeron, Erin S. Mackinnon, G.B. John Mancini · 2024 · Reviews in Cardiovascular Medicine
23. The Role of Lipoprotein(a) in Peripheral Artery Disease
    Nicholas Pavlatos, Dinesh Kumar Kalra · 2024 · Biomedicines
24. Lipid-Lowering Therapy and Cardiovascular Prevention in Elderly
    Francesco Baratta, Federica Moscucci, Ilaria Lospinuso, Nicholas Cocomello, Alessandra Colantoni, Alessia Di Costanzo, Daniele Tramontano, Laura D’Erasmo, Daniele Pastori, Evaristo Ettorre et al. · 2025 · Drugs
25. Subclinical Hypothyroidism with TSH>7 mIU/l and≤10 mIU/l and Coronary Artery Disease
    Pedro Weslley Rosário, Maria Regina Calsolari · 2020 · Hormone and Metabolic Research
26. Development of Fatty Acid Reference Ranges and Relationship with Lipid Biomarkers in Middle-Aged Healthy Singaporean Men and Women
    Cody A. C. Lust, Xinyan Bi, Christiani Jeyakumar Henry, David W.L. · 2021 · Nutrients
27. Who would benefit most from postprandial lipid screening?
    Christina M. Sciarrillo, Nicholas A. Koemel, Bryant H. Keirns, Nile F. Banks, Emily M. Rogers, Sara K. Rosenkranz, Stephanie P. Kurti, Nathaniel D.M. Jenkins, Sam R. Emerson · 2021 · Clinical Nutrition
28. The Association Between Route of Post-menopausal Estrogen Administration and Blood Pressure and Arterial Stiffness in Community-Dwelling Women
    Cindy Z. Kalenga, Jacqueline L. Hay, Kevin F. Boreskie, Todd Ashley Duhamel, Jennifer M. MacRae, Amy Metcalfe, Kara A. Nerenberg, Magali Robert, Sofia Bano Ahmed · 2022 · Frontiers in Cardiovascular Medicine
29. Lipoprotein(a): Insights for the Practicing Clinician
    Pyotr Telyuk, David Austin, Ahai Luvai, Azfar Zaman · 2022 · Journal of Clinical Medicine
30. Sex Differences in Cardiac Medication Use Post-Catheterization in Patients Undergoing Coronary Angiography for Stable Angina with Nonobstructive Coronary Artery Disease
    Shannon Galway, Falisha Adatia, Maja Grubisić, May Lee, Patrick Daniele, Karin H. Humphries, Tara Sedlak · 2017 · Journal of Women s Health
31. Effect of a low glycemic index diet versus a high-cereal fibre diet on markers of subclinical cardiac injury in healthy individuals with type 2 diabetes mellitus: An exploratory analysis of a randomized dietary trial
    Vanessa Ha, Effie Viguiliouk, Cyril W.C. Kendall, Balachandran Bashyam, David J.A. Jenkins, Peter A. Kavsak, John L. Sievenpiper · 2017 · Clinical Biochemistry
32. Role of new imaging modalities in pursuit of the vulnerable plaque and the vulnerable patient
    Paolo Raggi, Gianluca Pontone, Daniele Andreini · 2017 · International Journal of Cardiology
33. Generation and characterization of LPA-KIV9, a murine monoclonal antibody binding a single site on apolipoprotein (a)
    Ayelet Gonen, Xiaohong Yang, Calvin Yeang, Elena A. Alekseeva, Marlys L. Koschinsky, Joseph Lee Witztum, Michael B. Boffa, Sotirios Tsimikas · 2020 · Journal of Lipid Research
34. Changing dietary approaches to prevent cardiovascular disease
    Paul John Nestel, Lawrence Joseph Beilin, Trevor Anthony Mori · 2020 · Current Opinion in Lipidology
35. R x IALTA: evaluating the effect of a pharmacist-led intervention on CV risk in patients with chronic inflammatory diseases in a community pharmacy setting: a prospective pre–post intervention study
    Yazid N. Al Hamarneh, Carlo A. Marra, Robert Gniadecki, Stephanie Keeling, Andrea Morgan, Ross T. Tsuyuki · 2021 · BMJ Open
36. Lipoprotein (a) is associated with poor long-term prognosis in patients aged 80 years and older with acute coronary syndrome
    Tiantian Sang, Nan Cheng, Aimin Dang, Naqiang Lv, Wei Zhang, Yifan Li, Yinze Ji, Yingzhen Gu · 2021 · Journal of clinical lipidology
37. The Riskier Lipid: What Is on the HORIZON for Lipoprotein (a) and Should There Be Lp(a) Screening for All?
    Stephen James Nicholls, Kristen J. Bubb · 2021 · Current Cardiology Reports
38. Are all fibres created equal with respect to lipid lowering? Comparing the effect of viscous dietary fibre to non-viscous fibre from cereal sources: a systematic review and meta-analysis of randomised controlled trials
    Elena Jovanovski, Michelle Nguyen, Yui Kurahashi, Allison Komishon, Dandan Li, Ho Hoang Vi Thanh, Rana Khayyat, Alexandra L. Jenkins, Tauseef Ahmad Khan, Andreea Zurbau et al. · 2022 · British Journal Of Nutrition
39. Low Subjective Cardiovascular Disease Risk Perceptions among Hypertensive Patients in Addis Ababa, Ethiopia
    Daniel Mengistu, Dejuma Yadeta, Alemayehu Worku Yalew, Melinda Kay Higgins, REBECCA A. GARY · 2022 · Integrated Blood Pressure Control
40. Prognostic value of low-density lipoprotein cholesterol in IgA nephropathy and establishment of nomogram model
    Zhang-yu Tian, Aimei Li, Ling Chu, Jing Hu, Xie Xian, Hao Zhang · 2023 · Frontiers in Endocrinology
41. Patient perceptions about obesity management in the context of concomitant care for other chronic diseases
    Ian T. Patton, Ximena Ramos Salas, Brad Hussey, Megha Poddar, Sanjeev Sockalingam, Laurie Twells, Hassan R. Mir, Mary A. Forhan, Pam Hung, Al Martin et al. · 2023 · Obesity Pillars
42. Longitudinal Control of Lipid Levels in Patients With Premature Coronary Artery Disease
    Diana N. Vikulova, Danielle Pinheiro-Muller, Carlos H. Rojas‐Fernandez, Francois Leblond, Simon Neil Pimstone, Liam R. Brunham · 2023 · JACC Advances
43. Lipoprotein(a) testing in lipid clinics across the UK: Results of a national survey
    Saleem Ansari, R. Dermot G. Neely, Jules Payne, Jaimini Cegla · 2024 · Journal of clinical lipidology
44. Growth differentiation factor-15 predicts all-cause death and major adverse cardiovascular events in patients with coronary heart disease: a prospective cohort study
    Lyu Lyu, Cui Xv, Juan Xu, Zhenzhen Liu, HE Yan-ru, Wenjing Zhu, Lin Lin, Qiang Yang, Yun Wei, Jinda Wang et al. · 2024 · Journal of Thrombosis and Thrombolysis
45. Low prevalence of testing for apolipoprotein B and lipoprotein (a) in the real world
    Dana J. Murdock, Keran Moll, Robert J. Sanchez, Jing Gu, Sergio Fazio, Gregory P. Geba, Fátima Rodríguez · 2024 · American Journal of Preventive Cardiology
46. The Portfolio Diet and HbA1c in Adults Living with Type 2 Diabetes Mellitus: A Patient-Level Pooled Analysis of Two Randomized Dietary Trials
    Meaghan E Kavanagh, Songhee Back, Victoria Chen, Andrea J. Glenn, Gabrielle Viscardi, Zeinab Houshialsadat, John L. Sievenpiper, Cyril W.C. Kendall, David J.A. Jenkins, Laura Chiavaroli · 2024 · Nutrients
47. Statin-Associated Muscle Symptoms: Identification and Recommendations for Management
    Kevin Carl Maki, Carol F. Kirkpatrick, Mary Katherine Cheeley, Terry A. Jacobson · 2024 · Current Atherosclerosis Reports
48. Deficient perceptions and practices concerning elevated lipoprotein(a) among specialists in Singapore
    Wann Jia Loh, Jing Pang, Oliver Simon, Dick C. Chan, Gerald Francis Watts · 2025 · Frontiers in Cardiovascular Medicine
49. High-Sensitivity C-Reactive Protein Combined with Low-Density Lipoprotein Cholesterol as the Targets of Statin Therapy in Patients with Acute Coronary Syndrome
    Ming Fang, Qiaohui Qian, Zhihong Zhao, Luoning Zhu, Jin-wen Su, Xinming Li · 2018 · International Heart Journal
50. Lipids and Lipoproteins in Risk Prediction
    Savvas Hadjiphilippou, Kausik Kumar Ray · 2018 · Cardiology Clinics
51. Fasting-Evoked En Route Hypoglycemia in Diabetes (FEEHD): An Overlooked Form of Hypoglycemia in Clinical Practice
    Saleh A. Aldasouqi, Samia Mora, Gaurav Bhalla, Naveen Kakumanu, William D. Corser, George S. Abela, Mohammad M Dlewati, Kathleen Estrada, Abdul Almounajed, Tarek Tabbaa et al. · 2018 · International Journal of Endocrinology
52. Documento de consenso de un grupo de expertos de la Sociedad Española de Arteriosclerosis (SEA) sobre el uso clínico de la resonancia magnética nuclear en el estudio del metabolismo lipoproteico (Liposcale)
    Xavier Pintó, L. Masana, Fernando Civeira, José Manuel Fernández‐Real, Daiana Ibarretxe, Beatriz Candás‐Estébanez, José Puzo, José Luis Díaz-Díaz, Núria Amigó, Margarita Esteban et al. · 2020 · Clínica e Investigación en Arteriosclerosis
53. Frequency of laboratory testing and associated abnormalities in patients with hypertension
    Samuel Quan, Guanmin Chen, Raj S. Padwal, Finlay Aleck McAlister, Karen C. Tran, Norm R.C. Campbell, Zhiying Liang, Yuanchao Feng, Doreen M. Rabi, Alexander A. C. Leung · 2020 · Journal of Clinical Hypertension
54. Prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with coronary heart disease in Xinjiang, China
    Ting-ting Wang, Li Sun, Li Xu, Ting Zhao, Jie Feng, Lu‐hai Yu, Jianhua Wu, Hongjian Li · 2021 · Lipids in Health and Disease
55. Effect of an Exercise and Nutrition Program on Quality of Life in Patients With Atrial Fibrillation: The Atrial Fibrillation Lifestyle Project (ALP)
    Jesse Bittman, Cynthia J. Thomson, Lloyd A. Lyall, Stephanie L. Alexis, Eric Lyall, Sebastian L. Cannatella, Mahasti Ebtia, Alexander Fritz, Benjamin K. Freedman, Nooshin Alizadeh-Pasdar et al. · 2022 · CJC Open
56. UPDATE – Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies (Full-text)
    Andrea Kokorovic, Alan So, Hosam A. Serag, Christopher French, Robert James Hamilton, Jason Izard, Jasmir Gopal Nayak, Frédéric Pouliot, Fred Saad C, Bobby Shayegan et al. · 2022 · Canadian Urological Association Journal
57. Approach to risk stratification of atherosclerotic cardiovascular disease
    Daniel Esau, Beth L. Abramson · 2022 · Canadian Family Physician
58. A Woman’s Heart: Improving Uptake and Awareness of Cardiovascular Screening for Middle-Aged Populations
    Brigitte E. Kazzi, Bairavi Shankar, Petal Elder-Odame, Lale S Tokgözoğlu, Lilia M. Sierra-Galán, Erin D. Michos · 2023 · International Journal of Women s Health
59. Using Polygenic Risk Scores for Prioritizing Individuals at Greatest Need of a Cardiovascular Disease Risk Assessment
    Ryan Chung, Zhe Xu, Matthew Arnold, Samantha Ip, Hannah Harrison, Jessica Barrett, Lisa A M Pennells, Lois G. Kim, Emanuele Di Angelantonio, Ellie Paige et al. · 2023 · Journal of the American Heart Association
60. Non-HDL-c/TC: A Novel Lipid-Related Marker in the Assessment of Severity of Coronary Artery Lesions and Cardiovascular Outcomes
    Anan Huang, Xin Qi, Liping Wei, Mingyin Zhang, Shiqi Zhou · 2019 · Cardiology Research and Practice
61. Deteriorated Cardiometabolic Risk Profile in Individuals with Excessive Blood Pressure Response to Submaximal Exercise.
    Charles Côté, Caroline Rhéaume, P. Poirier, J. Despres, N. Alméras · 2019 · American Journal of Hypertension
62. Lipid findings from the Diabetes Education to Lower Insulin, Sugars, and Hunger (DELISH) Study
    Ashley E. Mason, Laura R. Saslow, Patricia J. Moran, Sarah Kim, Hiba Abousleiman, Robert Richler, Samantha Schleicher, Veronica M. Goldman, Alison R. Hartman, Cindy W. Leung et al. · 2019 · Nutrition & Metabolism
63. Evaluating the diagnostic and prognostic value of biomarkers for heart disease and major adverse cardiac events in patients with muscular dystrophy
    Anish Nikhanj, Bailey Miskew Nichols, Kaiming Wang, Zaeem Azfer Siddiqi, Gavin Y. Oudit · 2020 · European Heart Journal - Quality of Care and Clinical Outcomes
64. Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study
    Henock G. Yebyo, Sofia Zappacosta, Hélène Eloise Aschmann, Sarah Roberta Haile, Milo Alan Puhan · 2020 · BMC Cardiovascular Disorders
65. Medical Management of Peripheral Arterial Disease: Deciphering the Intricacies of Therapeutic Options
    Sanjot S. Sunner, Robert C. Welsh, Kevin R. Bainey · 2021 · CJC Open
66. Which Diets Are Effective in Reducing Cardiovascular and Cancer Risk in Women with Obesity? An Integrative Review
    Érika Aparecida Silveira, Priscilla Rayanne e Silva Noll, Noushin Mohammadifard, Ana Paula dos Santos Rodrigues, Nizal Sarrafzadegan, Cesar Messias de Oliveira · 2021 · Nutrients
67. Fasting status modifies the association between triglyceride and all‐cause mortality: A cohort study
    Yan Fang, Yutang Wang · 2022 · Health Science Reports
68. Predicted heart age profile across 41 countries: A cross-sectional study of nationally representative surveys in six world regions
    Wilmer Cristobal Guzman‐Vilca, Gustavo A. Quispe-Villegas, Rodrigo Martin Carrillo-Larco · 2022 · EClinicalMedicine
69. Framework of Guidelines for Management of CKD in Asia
    Carol A. Pollock, Juyoung Moon, Le Pham Ngoc Ha, Pongsathorn Gojaseni, Chen Hua Ching, Lynn Gomez, Tak Mao Chan, Ming‐Ju Wu, See Cheng Yeo, Pringgodigdo Nugroho et al. · 2023 · Kidney International Reports
70. Cardiovascular multimodality imaging in women: a scientific statement of the European Association of Cardiovascular Imaging of the European Society of Cardiology
    Ana G. Almeida, Julia Grapsa, Alessia Gimelli, Chiara Bucciarelli‐Ducci, Bernhard L. Gerber, Nina Ajmone Marsan, Anne Bernard, Erwan Donal, Marc Richard Dweck, Kristina Hermann Haugaa et al. · 2024 · European Heart Journal - Cardiovascular Imaging
71. Adoption of the PREVENT (Predicting Risk of Cardiovascular Disease EVENTs) Risk Algorithm
    G.B. John Mancini, Arnold Ryomoto · 2024 · JACC Advances
72. Calcified carotid artery atheroma on standard dental radiographs: A public health opportunity for cardiovascular risk reduction
    Vicky Mai, Aneesha Taneja, Hannu Larjava, Babak Chehroudi, David MacDonald, Christina L. Luong · 2024 · American Journal of Preventive Cardiology
73. Use of Olives-derived Phytochemicals for Prevention and Treatment of Atherosclerosis: An Update
    Siarhei A. Dabravolski, Elizaveta Pleshko, Vasily N. Sukhorukov, Victor Yu. Glanz, Igor Alexandrovich Sobenin, Alexander Nikolaevich Orekhov · 2024 · Current Topics in Medicinal Chemistry
74. Rationale for the routine screening of Lipoprotein(a) in cardiovascular risk assessment
    Iulia Iatan, Marlys L. Koschinsky, Logan Trenaman, Wei Zhang, George Thanassoulis, Liam R. Brunham, G.B. John Mancini, Gordon A. Francis · 2025 · European Journal of Preventive Cardiology
75. Lipoprotein(a): lodestar for future clinical trials
    Gerald Francis Watts, Michael B. Boffa · 2018 · The Lancet
76. Meal Replacements for Weight-Related Complications in Type 2 Diabetes: What Is the State of the Evidence?
    Jarvis Clyde Noronha, Cyril W.C. Kendall, John L. Sievenpiper · 2022 · Frontiers in Endocrinology
77. Clinical effects of Emblica officinalis fruit consumption on cardiovascular disease risk factors: a systematic review and meta-analysis
    Paul D. S. Brown, Nicole I. Ketter, Mathew Vis‐Dunbar, Brodie M. Sakakibara · 2023 · BMC Complementary Medicine and Therapies
78. Real-World Risk of Recurrent Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with LDL-C Above Guideline-Recommended Threshold: A Retrospective Observational Study
    Erin S. Mackinnon, Lawrence A. Leiter, Rajvi J. Wani, Natasha Burke, Eileen Shaw, Kelcie Witges, Shaun G. Goodman · 2024 · Cardiology and Therapy
79. Optimizing Post-Acute Coronary Syndrome Dyslipidemia Management: Insights from the North American Acute Coronary Syndrome Reflective III
    Meshal Alanezi, Andrew Tze-Kay Yan, Mary Tan, Ronald Leonard Bourgeois, P Malek-Marzban, Rani Beharry, Suhaib Al-Kurtass, Gabor T. Gyenes, Pierre-Louis Nadeau, Nduka Francis Nwadiaro et al. · 2024 · Cardiology
80. Cardiovascular Risk Reduction in the Workplace With CAMMPUS (Cardiovascular Assessment and Medication Management by Pharmacists at the UBC Site)
    Barbara Gobis, Anita I. Kapanen, Jillian Reardon, Jason K. Min, Kathy H. Li, Larry David Lynd, Peter J. Zed · 2019 · Annals of Pharmacotherapy
81. How Low to Go With Lipid-Lowering Therapies in a Cost-effective and Prudent Manner
    Rhanderson N. Cardoso, Roger Scott Blumenthal, Stephen Louis Kopecky, Francisco Alejandro López-Jiménez, Seth Shay Martin · 2019 · Mayo Clinic Proceedings
82. Non-invasive measurements of arterial function: What? When? Why should we use them?
    Zoe Dong Yang Sun, Joseph Cheriyan · 2019 · Heart
83. Guidelines about physical activity and exercise to reduce cardiometabolic risk factors: protocol for a systematic review and critical appraisal
    Madelin R. Siedler, Mohammad Hassan Murad, Yngve T Falck-Ytter, Philipp Dahm, Reem A. Mustafa, Shahnaz Sultan, Rebecca L. Morgan · 2020 · BMJ Open
84. Mental health is correlated with lipoprotein(a) levels in male patients with premature coronary heart disease
    Jinlan Bao, Shaoxin Zheng, Jingjing Huang, Xiangkun Xie, Jinglu Zhang, Shiliang Yang, Xiaoying Wu, Yuling Zhang · 2021 · Annals of Palliative Medicine
85. High-density lipoprotein, low-density lipoprotein and triglyceride levels and upper gastrointestinal cancers risk: a trans-ancestry Mendelian randomization study
    Yanling Wu, Junyi Xin, Elizabeth A. Loehrer, Xia Jiang, Qianyu Yuan, David C. Christiani, Hanping Shi, Lingxiang Liu, Shuwei Li, Meilin Wang et al. · 2022 · European Journal of Clinical Nutrition
86. A Bayesian Network Analysis of the Probabilistic Relationships Between Various Obesity Phenotypes and Cardiovascular Disease Risk in Chinese Adults: Chinese Population-Based Observational Study
    Simiao Tian, Mei Bi, Yanhong Bi, Xiaoyu Che, Yazhuo Liu · 2022 · JMIR Medical Informatics
87. Triglyceride content increases while cholesterol content decreases in HDL and LDL+IDL fractions following normal meals: The Copenhagen General Population Study of 25,656 individuals
    Mia Ø Johansen, Juan Moreno‐Vedia, Mie Balling, George Davey Smith, Børge Grønne Nordestgaard · 2023 · Atherosclerosis
88. Age-specific and sex-specific reference intervals for non-fasting lipids and apolipoproteins in 7260 healthy Chinese children and adolescents measured with an Olympus AU5400 analyser: a cross-sectional study
    Junjie Liu, Yanpeng Dai, Enwu Yuan, Yushan Li, Quanxian Wang, Linkai Wang, Yanhua Su · 2019 · BMJ Open
89. Cardiovascular risk prediction tools made relevant for GPs and patients
    Tamar I. de Vries, Frank L.J. Visseren · 2020 · Heart
90. Dyslipidemia in Diabetes
    Savitha Subramanian, Alan Chait · 2018 · Elsevier eBooks
91. CAR and CSTR Cardiac Computed Tomography (CT) Practice Guidelines: Part 1 Coronary CT Angiography (CCTA)
    Elsie T. Nguyen, Courtney R. Green, Scott Adams, Helen Bishop, Guylaine Gleeton, Cameron John Hague, Kate A Hanneman, Scott R. Harris, Jacek Strzelczyk, Carole J. Dennie · 2024 · Canadian Association of Radiologists Journal
92. High dose cholecalciferol supplementation causing morning blood pressure reduction in patients with type 1 diabetes mellitus and cardiovascular autonomic neuropathy
    João Soares Felício, Lorena Vilhena de Moraes, Gabriela Lemos, Ícaro José Araújo de Souza, Giovana Carvalho Vieira, Lilian de Souza D’Albuquerque Silva, Natércia Neves Marques de Queiroz, Ana Carolina Souza, Franciane Trindade Cunha de Melo, João Felício Abrahão Neto et al. · 2024 · Scientific Reports
93. Lipoprotein(a) is a Prevalent yet Vastly Underrecognized Risk Factor for Cardiovascular Disease
    Jacob Rendler, Mia Murphy, Calvin Yeang · 2024 · ASEAN Journal of Psychiatry
94. Trends and findings of lipoprotein(a) testing and associated cardiovascular disease profiles: a large single-center study from the Middle East-Gulf region
    Yosef Manla, Laila AbdelWareth, Ronney S. Shantouf, Yazan Aljabery, Terrence Lee St John, Hani Mohamed Sabbour, Bartłomiej Piechowski‐Jóźwiak, Wael A. Almahmeed · 2024 · Frontiers in Cardiovascular Medicine
95. Black phosphorus quantum dots prevent atherosclerosis in high-fat diet-fed apolipoprotein E knockout mice
    Yiran Ji, Yilin Wen, Shengwei Zhang, Bingxuan Xu, Shuai Sun, Yun Chen, Xintao Shuai, Tingting Zheng · 2024 · Aging
96. Lipoprotein (a) as a Cardiovascular Risk Factor in Controversial Clinical Scenarios: A Narrative Review
    Hesham Abdalla, Ahmed Mahmoud, Ahmed E. Khedr, Juan Farina, Isabel G. Scalia, Mohammed Tiseer Abbas, Kamal Awad, Nima Baba Ali, Nadera Naquib Bismee, Sogol Attaripour Esfahani et al. · 2024 · International Journal of Molecular Sciences
97. Immuno-inflammatory mechanisms in cardio-oncology: new hopes for immunotargeted therapies
    Meiqi Miao, Xinxin Liu, Han Zhang, Hailong Dai · 2025 · Frontiers in Oncology
98. Association between FIB-4 index and lower extremity arterial disease in MASLD patients: a cross-sectional study
    Chunxia Zhang, Yuchen Ying, Yuanhui Ru, Ziliang Wu, Yumeng Tian, Pingping Shen, Shiyuan Cao, Jing Zhang, Ri Liu · 2025 · Lipids in Health and Disease
99. Lipoprotein(a) in youth and childhood as a marker of cardiovascular risk stratification: a meta-analysis
    Irene Borzillo, Fabrizio D ́ascenzo, Emanuele Ravetti, Marco Balducci, Riccardo Pilia, Matteo Michelone, Giuseppe Annoni, Alessandra Toscano, Giuseppe Giannino, Gaetano Maria De Ferrari et al. · 2025 · Journal of Cardiovascular Medicine
100. Joint BrEast CAncer & CardiOvascular ScreeniNg: BEACON Study to Assess Opportunistic Cardiovascular Screening Using Breast Arterial Calcification on Mammography
     Hayley McKee, Teresa Bianco, Kaitlin M. Zaki-Metias, Vivianne Freitas, Sandeep Ghai, Kate A Hanneman, Jean Morag Seely, Charlotte Jane Yong-Hing, Husam Mohamed Abdel-Qadir, Paula Harvey et al. · 2025 · Canadian Association of Radiologists Journal